Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ruxandra Mitre"'
Autor:
Horia-Dan Liscu, Bogdan-Radu Liscu, Ruxandra Mitre, Ioana-Valentina Anghel, Ionut-Lucian Antone-Iordache, Andrei Balan, Simona Coniac, Andreea-Iuliana Miron, Georgian Halcu
Publikováno v:
Medicina, Vol 59, Iss 7, p 1224 (2023)
The management of locally advanced rectal cancer (LARC) suffered changes thanks to the development of improved surgical procedures, radiation delivery, and chemotherapy. Although treatment options improved individually, the optimal order is still deb
Externí odkaz:
https://doaj.org/article/993ec353a6a1444e94872185234f8418
Autor:
Andreea-Iuliana Miron, Alexandra-Valentina Anghel, Andrei-Alexandru Barnonschi, Ruxandra Mitre, Horia-Dan Liscu, Estera Găinariu, Raluca Pătru, Simona Coniac
Publikováno v:
Diagnostics, Vol 13, Iss 11, p 1938 (2023)
The introduction in clinical practice of selective cyclin-dependent kinase (CDK) 4/6 inhibitors improves the outcome of patients with hormone receptor (HR)-positive human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (mB
Externí odkaz:
https://doaj.org/article/8cf14f19114f4adf9ec2e977a9c85a47
Autor:
Halcu, Horia-Dan Liscu, Bogdan-Radu Liscu, Ruxandra Mitre, Ioana-Valentina Anghel, Ionut-Lucian Antone-Iordache, Andrei Balan, Simona Coniac, Andreea-Iuliana Miron, Georgian
Publikováno v:
Medicina; Volume 59; Issue 7; Pages: 1224
The management of locally advanced rectal cancer (LARC) suffered changes thanks to the development of improved surgical procedures, radiation delivery, and chemotherapy. Although treatment options improved individually, the optimal order is still deb
Autor:
Coniac, Andreea-Iuliana Miron, Alexandra-Valentina Anghel, Andrei-Alexandru Barnonschi, Ruxandra Mitre, Horia-Dan Liscu, Estera Găinariu, Raluca Pătru, Simona
Publikováno v:
Diagnostics; Volume 13; Issue 11; Pages: 1938
The introduction in clinical practice of selective cyclin-dependent kinase (CDK) 4/6 inhibitors improves the outcome of patients with hormone receptor (HR)-positive human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (mB
Autor:
Horia-Dan, Liscu, Andreea-Iuliana, Miron, Andra-Raluca, Rusea, Ana-Maria Nicoleta, Oprea, Ruxandra, Mitre, Alexandru, Herdea, Razvan, Negreanu
Publikováno v:
Maedica (Bucur)
Neoadjuvant treatment has become the standard of care for locally advanced rectal cancer for many years. Several neoadjuvant therapeutic options are currently used, the most common being conventionally fractionated radiotherapy (or long-course radiot